Compare Oscar Health Inc (OSCR) vs Redwire Corporation (RDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Redwire Corporation — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while Redwire Corporation trades at $9.58 (market cap $2.44B). The key difference: Oscar Health Inc is far larger — about 4.2× Redwire Corporation's market cap, and Oscar Health Inc is trading nearer its 52-week high, Redwire Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Redwire Corporation for 18 Days on average.
| OSCR | RDW | |
|---|---|---|
Market Cap | $10.22B | $2.44B |
Volume | 4,123,394 | 11,053,212 |
Sector | Health | Industrials |
52-Week High | $33.81 | $25.90 |
52-Week Low | $10.85 | $5.06 |
Typical Hold Time | 15 Days | 18 Days |
Enterprise Value | $6.57B | $1.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
RDW trades at $9.58, down 6.45% today, with technical indicators showing bearish momentum despite oversold RSI readings near 27. The company reported significant losses with a -57.26% net income margin and negative cash flow from operations, though revenue grew to $335M in 2025. Recent Space Force contract wins and partnerships highlight growth potential in defense and space infrastructure markets.
While analyst consensus remains bullish with an 80% buy rating and $14.88 price target, RDW faces substantial execution risks from persistent losses and dependence on SpaceX's Starship success. The stock offers high-risk exposure to the growing space economy but requires careful monitoring of profitability improvements and contract execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Redwire Corporation
Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.
Read more on RDW →
